Pfizer slides as analysts move to sidelines following Mylan deal, guidance cut - InvestingChannel

Pfizer slides as analysts move to sidelines following Mylan deal, guidance cut

Shares of Pfizer (PFE) are under pressure after both Morgan Stanley and Bank of America Merrill Lynch downgraded the stock to Neutral-equivalent ratings. Morgan Stanley analyst… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id2941110/-Pfizer-slides-as-analysts-move-to-sidelines-following-Mylan-deal-guidance-cut)